Yüklüyor......
Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease
Allogeneic stem cell transplantation (allo-SCT) is the only curative option for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Azacitidine (AZA) has a good toxicity profile compared with intensive chemotherapy and can be considered a pre-transplant regimen in elderly patients and i...
Kaydedildi:
| Yayımlandı: | Hematol Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
PAGEPress Publications, Pavia, Italy
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477469/ https://ncbi.nlm.nih.gov/pubmed/28670436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2017.7114 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|